Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Whole exome sequencing identifies a recurrent RQCD1 P131L mutation in cutaneous melanoma

Wong SQ, Behren A, Mar VJ, Woods K, Li J, Martin C, Sheppard KE, Wolfe R, Kelly J, Cebon J, Dobrovic A, McArthur GA

(2015), Oncotarget, 6(2), 1115-27

Postexcisional melanocytic regrowth extending beyond the initial scar: a novel clinical sign of melanoma

Kelly JW, Shen S, Pan Y, Dowling J, McLean CA

(2014), Br J Dermatol, 170(4), 961-4

Liability in the context of misdiagnosis of melanoma in Australia

Abikhair MR, Mahar PD, Cachia AR, Kelly JW

(2014), Med J Aust, 200(2), 119-21

Dermoscopic characteristics of nodular squamous cell carcinoma and keratoacanthoma

Lin MJ, Pan Y, Jalilian C, Kelly JW

(2014), Dermatol Pract Concept, 4(2), 9-15

Atypical Spitzoid neoplasms: a review of potential markers of biological behavior including sentinel node biopsy

McCormack CJ, Conyers RK, Scolyer RA, Kirkwood J, Speakman D, Wong N, Kelly JW, Henderson MA

(2014), Melanoma Res, 24(5), 437-47

Emergence of chemoresistance in a metastatic basal cell carcinoma patient after complete response to hedgehog pathway inhibitor vismodegib (GDC-0449)

Meani RE, Lim SW, Chang AL, Kelly JW

(2014), Australas J Dermatol, 55(3), 218-21

Diagnostic accuracy of malignant melanoma according to subtype

Lin MJ, Mar V, McLean C, Wolfe R, Kelly JW

(2014), Australas J Dermatol, 55(1), 35-42

An objective measure of growth rate using partial biopsy specimens of melanomas that were initially misdiagnosed

Lin MJ, Mar V, McLean C, Kelly JW

(2014), J Am Acad Dermatol, 71(4), 691-7

Clinical and pathological associations of the activating RAC1 P29S mutation in primary cutaneous melanoma

Mar VJ, Wong SQ, Logan A, Nguyen T, Cebon J, Kelly JW, Wolfe R, Dobrovic A, McLean C, McArthur GA

(2014), Pigment Cell Melanoma Res, 27(6), 1117-25

Characteristics and associations of high-mitotic-rate melanoma

Shen S, Wolfe R, McLean CA, Haskett M, Kelly JW

(2014), JAMA Dermatol, 150(10), 1048-55

BRAF/NRAS wild-type melanomas have a high mutation load correlating with histological and molecular signatures of UV damage

Mar VJ, Wong SQ, Li J, Scolyer RA, McLean C, Papenfuss AT, Tothill RW, Kakavand H, Mann GJ, Thompson JF, Behren A, Cebon JS, Wolfe R, Kelly JW, Dobrovic A, McArthur GA

(2013), Clin Cancer Res, 19(17), 4589-98

Clinical and dermoscopic characteristics of Merkel cell carcinoma

Jalilian C, Chamberlain AJ, Haskett M, Rosendahl C, Goh M, Beck H, Keir J, Varghese P, Mar A, Hosking S, Hussain I, Rich M, McLean C, Kelly JW

(2013), Br J Dermatol, 169(2), 294-7

Neuropathy in a patient with lymphocytic thrombophilic arteritis

Shen S, Williams RA, Kelly RI

(2013), Australas J Dermatol, 54(2), e28-32

Nodular melanoma: a distinct clinical entity and the largest contributor to melanoma deaths in Victoria, Australia

Mar V, Roberts H, Wolfe R, English DR, Kelly JW

(2013), J Am Acad Dermatol, 68(4), 568-75

Pharmacotherapy for skin disorders in older people

Shen S, Kelly RI

(2012), J Pharm Pract Res, 42(2), 150-4

The use of methotrexate in dermatology: a review

Shen S, O'Brien T, Yap LM, Prince HM, McCormack CJ

(2012), Australas J Dermatol, 53(1), 1-18

Photographic artefact simulating regressing melanocytic lesion: a potential pitfall of total body photography

Edwards SP, Chamberlain AJ

(2012), Australas J Dermatol, 53(4), 314-5

Reply

Ly L, Winship I, Kelly JW

(2012), J Am Acad Dermatol, 66(2), 325-6

Beware blind spots!

Edwards S, Chamberlain AJ

(2011), Med Today, 12(6), 65-7

Melanoma(s) arising in large segmental speckled lentiginous nevi: a case series

Ly L, Christie M, Swain S, Winship I, Kelly JW

(2011), J Am Acad Dermatol, 64(6), 1190-3

4 5 6 7 8